Related Experiment Video
Updated: Jul 15, 2026
11:27
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
The serotonin signaling system: from basic understanding to drug development for functional GI disorders
1Department of Pathology & Cell Biology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. mdg4@columbia.edu
Gastroenterology
|January 24, 2007
Summary
Serotonin, a key gastrointestinal signaling molecule, plays a vital role in gut function and brain-gut disorders. Targeting serotonin receptors offers promising therapeutic strategies for various digestive conditions.
Area of Science:
- Gastroenterology
- Neuroscience
- Pharmacology
Background:
- Serotonin functions as a crucial paracrine messenger and neurotransmitter within the gastrointestinal tract.
- Enterochromaffin (EC) cells act as sensory transducers, utilizing serotonin to signal primary afferent neurons.
- Serotonin synthesis involves tryptophan hydroxylases (TpH1 and TpH2) in EC cells and neurons, respectively.
Purpose of the Study:
- To elucidate the multifaceted roles of serotonin in gastrointestinal signaling and function.
- To explore the therapeutic potential of modulating serotonergic pathways for digestive disorders.
- To review current and emerging pharmacological interventions targeting serotonin receptors.
Main Methods:
- Review of existing literature on serotonin's role in the gut.
- Analysis of the mechanisms of serotonin synthesis and inactivation (SERT).
- Examination of the pharmacology of serotonin receptor subtypes and their therapeutic applications.
Main Results:
- Serotonin modulates gastrointestinal motility, secretion, and sensation by activating intrinsic and extrinsic primary afferent neurons.
- Abnormalities in serotonergic signaling are implicated in functional bowel diseases.
- Approved drugs like tegaserod (5-HT4 agonist) and alosetron (5-HT3 antagonist) demonstrate the clinical utility of targeting serotonin pathways.
Conclusions:
- Targeting specific serotonin receptor subtypes offers effective therapeutic strategies for conditions such as irritable bowel syndrome (IBS) and chemotherapy-induced nausea.
- Further research into serotonergic agents holds promise for novel treatments of brain-gut disorders.
- Understanding serotonin's complex roles is key to developing advanced therapies for gastrointestinal and neurological conditions.
More Related Videos
06:01Using An In Vitro Tissue Perfusion System to Detect the Functional Activities of Isolated Intestinal Tubes in Real Time
Published on: July 26, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:22Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...